Cargando…
Assurance in vaccine efficacy clinical trial design based on immunological responses
The assurance of a future clinical trial is a key quantitative tool for decision‐making in drug development. It is derived from prior knowledge (Bayesian approach) about the clinical endpoint of interest, typically from previous clinical trials. In this paper, we examine assurance in the specific co...
Autores principales: | Callegaro, Andrea, Zahaf, Toufik, Tibaldi, Fabian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292007/ https://www.ncbi.nlm.nih.gov/pubmed/34254347 http://dx.doi.org/10.1002/bimj.202100015 |
Ejemplares similares
-
Assessing correlates of protection in vaccine trials: statistical solutions in the context of high vaccine efficacy
por: Callegaro, Andrea, et al.
Publicado: (2019) -
Maximin design of cluster randomized trials with heterogeneous costs and variances
por: van Breukelen, Gerard J. P., et al.
Publicado: (2021) -
26. Is There a Correlation Between Reactogenicity and Immune Responses of the Adjuvanted Recombinant Zoster Vaccine (RZV)? A Post-hoc Analysis
por: Callegaro, Andrea, et al.
Publicado: (2021) -
Design aspects of COVID‐19 treatment trials: Improving probability and time of favorable events
por: Beyersmann, Jan, et al.
Publicado: (2021) -
A flexible design for advanced Phase I/II clinical trials with continuous efficacy endpoints
por: Mozgunov, Pavel, et al.
Publicado: (2019)